Vienna, Austria

Andreas Aspöck

USPTO Granted Patents = 4 

Average Co-Inventor Count = 13.3

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
4 patents (USPTO):

Title: The Innovative Contributions of Andreas Aspöck

Introduction

Andreas Aspöck is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. With a total of 4 patents to his name, Aspöck's work focuses on addressing critical health challenges through innovative solutions.

Latest Patents

Aspöck's latest patents include groundbreaking advancements in vaccine technology. One of his notable inventions is related to CMV vaccines. This patent provides genetically modified arenaviral vectors suitable for the prevention and treatment of cytomegalovirus infections and reactivation. The invention also encompasses pharmaceutical compositions and methods aimed at treating these infections.

Another significant patent involves HPV vaccines. This invention details genetically modified arenaviruses that serve as vaccines against neoplastic diseases or cancer. It includes pharmaceutical compositions and methods for preventing or treating infections that lead to neoplastic diseases, particularly those caused by oncogenic viruses. The patent specifically addresses conditions associated with Human Papillomavirus (HPV), such as cervical cancer and other related cancers.

Career Highlights

Andreas Aspöck is currently associated with Hookipa Biotech GmbH, where he continues to push the boundaries of vaccine research and development. His work is instrumental in advancing therapeutic options for serious viral infections and cancers.

Collaborations

Aspöck collaborates with esteemed colleagues in the field, including Klaus Orlinger and Thomas P Monath. Their combined expertise enhances the innovative potential of their research endeavors.

Conclusion

Andreas Aspöck's contributions to vaccine development are noteworthy and reflect his commitment to improving public health. His innovative patents in CMV and HPV vaccines demonstrate the potential for biotechnology to address pressing medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…